Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Sacks

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Journal of Virological Methods|November 1, 1995
Automated microneutralization: method and comparison with western blot for type-specific detection of herpes simplex antibodies in two pregnant populationsS M Garland, T N Lee, R L Ashley, et al.
JAMA|July 3, 1996
Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study GroupS L Sacks, F Y Aoki, F Diaz-Mitoma, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1984
Metabolic fate of (E)-5-(2-bromovinyl)-2'-deoxyuridine in herpes simplex virus- and mock-infected cellsN K Ayisi, E De Clercq, R A Wall, et al.
Canadian Medical Association Journal|September 1, 1983
Drug resistance in malaria: three cases and a reviewJ L Isaac-Renton, A L Koon, R M Chan, et al.
Molecular Pharmacology|April 1, 1987
Comparative metabolism of E-5-(2-bromovinyl)-2'-deoxyuridine and 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil in herpes simplex virus-infected cellsN K Ayisi, R A Wall, R J Wanklin, et al.
Sexually Transmitted Diseases|January 1, 1988
Chronic suppression for six months compared with intermittent lesional therapy of recurrent genital herpes using oral acyclovir: effects on lesions and nonlesional prodromesS L Sacks, R Fox, P Levendusky, et al.
Neurology|December 1, 1991
Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. II. Immunologic evaluationL F Kastrukoff, J J Oger, W W Tourtellotte, et al.
Journal of Medicinal Chemistry|July 1, 1991
Nucleic acid related compounds. 65. New syntheses of 1-(beta-D-arabinofuranosyl)-5(E)-(2-iodovinyl)uracil (IVAraU) from vinylsilane precursors. Radioiodine uptake as a marker for thymidine kinase positive herpes viral infectionsM J Robins, S Manfredini, S G Wood, et al.
Annals of Internal Medicine|December 1, 1989
Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?S L Sacks, R J Wanklin, D E Reece, et al.
Journal of Virology|May 1, 1997
Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovirJ J Sasadeusz, F Tufaro, S Safrin, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Journal of Virological Methods|November 1, 1995
Automated microneutralization: method and comparison with western blot for type-specific detection of herpes simplex antibodies in two pregnant populationsS M Garland, T N Lee, R L Ashley, et al.
JAMA|July 3, 1996
Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study GroupS L Sacks, F Y Aoki, F Diaz-Mitoma, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1984
Metabolic fate of (E)-5-(2-bromovinyl)-2'-deoxyuridine in herpes simplex virus- and mock-infected cellsN K Ayisi, E De Clercq, R A Wall, et al.
Canadian Medical Association Journal|September 1, 1983
Drug resistance in malaria: three cases and a reviewJ L Isaac-Renton, A L Koon, R M Chan, et al.
Molecular Pharmacology|April 1, 1987
Comparative metabolism of E-5-(2-bromovinyl)-2'-deoxyuridine and 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil in herpes simplex virus-infected cellsN K Ayisi, R A Wall, R J Wanklin, et al.
Sexually Transmitted Diseases|January 1, 1988
Chronic suppression for six months compared with intermittent lesional therapy of recurrent genital herpes using oral acyclovir: effects on lesions and nonlesional prodromesS L Sacks, R Fox, P Levendusky, et al.
Neurology|December 1, 1991
Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. II. Immunologic evaluationL F Kastrukoff, J J Oger, W W Tourtellotte, et al.
Journal of Medicinal Chemistry|July 1, 1991
Nucleic acid related compounds. 65. New syntheses of 1-(beta-D-arabinofuranosyl)-5(E)-(2-iodovinyl)uracil (IVAraU) from vinylsilane precursors. Radioiodine uptake as a marker for thymidine kinase positive herpes viral infectionsM J Robins, S Manfredini, S G Wood, et al.
Annals of Internal Medicine|December 1, 1989
Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?S L Sacks, R J Wanklin, D E Reece, et al.
Journal of Virology|May 1, 1997
Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovirJ J Sasadeusz, F Tufaro, S Safrin, et al.
Pageof 6